Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.

Autor: Ganti AK, Lee SJ, Vose JM, Devetten MP, Bociek RG, Armitage JO, Bierman PJ, Maness LJ, Reed EC, Loberiza FR Jr

Publikováno v: Journal of Clinical Oncology; 12/10/2007, Vol. 25 Issue 35, p5643-5648, 6p

Interplay between spirituality and religiosity on the physical and mental well-being of cancer survivors.

Autor: Cannon AJ; Department of Psychiatry, Stritch School of Medicine, Loyola University-Chicago, Maywood, IL, USA. anthony.j.cannon@gmail.com.; Hines VA Medical Center, 5000 S. 5th Av., Hines, IL, 60141, USA. anthony.j.cannon@gmail.com., Dokucu ME; Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Loberiza FR Jr; Department of Internal Medicine, Section of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Feb; Vol. 30 (2), pp. 1407-1417. Date of Electronic Publication: 2021 Sep 15.

Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.

Autor: Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Martin AS; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Pérez WS; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Steinert P; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Zhang MJ; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin., Chirnomas D; Pfizer Inc, New York, New York., Hoang CJ; Pfizer Inc, New York, New York., Loberiza FR Jr; Pfizer Inc, New York, New York., Saber W; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: wsaber@mcw.edu.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 May; Vol. 26 (5), pp. 884-892. Date of Electronic Publication: 2019 Dec 28.

Effect of Surgical Intervention on Survival of Patients With Clinical N2 Non-Small Cell Lung Cancer: A Veterans' Affairs Central Cancer Registry (VACCR) Database Analysis.

Autor: Ganti AK; Department of Internal Medicine, VA-Nebraska Western Iowa Health Care System †Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center ‡Department of Internal Medicine, Division of Oncology/Hematology, Creighton University Medical Center, Omaha, NE., Gonsalves W, Loberiza FR Jr, Aldoss I, Batra R, Silberstein PT, Subbiah SP, Kessinger A

Publikováno v: American journal of clinical oncology [Am J Clin Oncol] 2016 Apr; Vol. 39 (2), pp. 142-6.

Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

Autor: Bhatt VR; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Balasetti V; Department of Neurology, University of Nebraska Medical Center, Omaha, NE., Jasem JA; Department of Neurology, Ohio State University, Columbus, OH., Giri S; Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN., Armitage JO; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Loberiza FR Jr; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Bociek RG; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Bierman PJ; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Maness LJ; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Vose JM; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Fayad P; Department of Neurology, University of Nebraska Medical Center, Omaha, NE., Akhtari M; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE. Electronic address: mojtaba.akhtari@unmc.edu.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2015 Oct; Vol. 15 (10), pp. 606-11. Date of Electronic Publication: 2015 Jun 19.